Atlas Trials

The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

Clinical trial NCT00674453 · COMPLETED

Trial details

NCT number
NCT00674453
Sponsor
Ligand Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bone Loss
Start date
2004-09-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.